# Medical Engineering Technologies Ltd. – FDA Inspections

Source: https://www.keypedia.com/companies/medical-engineering-technologies-ltd/acff8bc8-290d-4a17-a428-db6bb16dd145

> Inspection records and compliance data for Medical Engineering Technologies Ltd.. 1 FDA inspection on record, last inspected April 30, 2024.

---

## Details

- Name: Medical Engineering Technologies Ltd.
- FEI Number: 3013221579
- Country Name: United States
- Address: United States
- Country: United States

## Related Documents

- FDA Inspection 1238589 - Medical Engineering Technologies Ltd. - 2024-04-30 — source: FDA, date: April 30, 2024

## Related Companies

- [ASC Laboratories, Inc.](https://www.keypedia.com/companies/asc-laboratories-inc/d23faa1c-ad3a-49e8-a617-09bef54b5efd)
- [Focus Scientific Services Inc. dba Focus Laboratories](https://www.keypedia.com/companies/focus-scientific-services-inc-dba-focus-laboratories/fb47efd2-3617-4f6b-9dd4-75e53fc10ccc)
- [Qualimax LLC](https://www.keypedia.com/companies/qualimax-llc/f55d9729-a19e-450f-938d-552b6c0e3eb0)
- [Beijing Zhongke PUYAN Science and Technology Co.,Ltd.](https://www.keypedia.com/companies/beijing-zhongke-puyan-science-and-technology-coltd/e10cb5a2-9aaa-49a7-b13e-0bde8c79b049)
- [Coherus Oncology, Inc.](https://www.keypedia.com/companies/coherus-oncology-inc/e7c70a55-21e3-4ecd-9323-28a32cd5903f)
- [SGS North America Inc](https://www.keypedia.com/companies/sgs-north-america-inc/9c5ff5d3-187a-438c-a428-ea2d0412e027)
- [Alphamed Formulations Private Limited](https://www.keypedia.com/companies/alphamed-formulations-private-limited/a249b855-c45b-4f52-9fd5-0689a5b3141f)
- [Rockline Industries](https://www.keypedia.com/companies/rockline-industries/31450810-c845-4bc0-81d1-6fcc5aa7e128)
- [Nuwill Research and Innovations Private Limited](https://www.keypedia.com/companies/nuwill-research-and-innovations-private-limited/c3dfec00-47a8-457d-a743-5f7112451166)
- [Rigel Pharmaceuticals Inc](https://www.keypedia.com/companies/rigel-pharmaceuticals-inc/d9eb0a68-bb3f-4db0-86ac-6e28322ce2b6)
